Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Aquestive Works with FDA to Resolve Hurdles for its New Sublingual Epinephrine Candidate

Hope on the Horizon: Ten Food Allergy Research Breakthroughs in 2025

Very Low-Dose Multi-Nut OIT Promising for Children with Multiple Food Allergies

DBV to Submit FDA Application After Viaskin Peanut Patch Achieves Goals in Phase 3 Trial

Mabylon Begins Human Clinical Trials of New Peanut Allergy Treatment

Sublingual Epinephrine for Anaphylaxis Receives Fast Track Designation from FDA

FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...

CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...

Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration

Positive Early Results with Fecal Microbiota Therapy for Peanut-Allergic Patients

Study Finds Microneedle Delivery Successful in Test of Peanut Allergy Immunotherapy

Intranasal Peanut Allergy Vaccine Takes Step Forward

Food Allergy Toothpaste Therapy: Positive News from Ongoing Phase 1 Trial

Food Allergy Prevention QuickFire Challenge: Up to $150,000 in Grant Funding...

FDA Clears Path for Human Clinical Trials of Peanut Allergy Vaccine

Your School On Our Map

Put Your School on the Map